PITTSBURGH, PA--(Marketwired - Nov 9, 2016) - As more and more individuals seek ways to enhance their appearance and reduce signs of age, new technologies continue to develop that give both men and women a number of options -- both surgical and non-surgical -- that are designed to achieve their goals. Dr. Paul Leong, a facial plastic surgeon in Pittsburgh, says one of the more revolutionary procedures to come along over the last few years is a non-surgical treatment called Ultherapy®, also known as Ulthera®. The FDA-approved treatment utilizes ultrasound technology to "lift" facial skin and provide patients with a smoother, more youthful appearance. Dr. Leong says, while the procedure is not for everyone, it can be very beneficial for those with mild to moderate signs of facial aging who are looking to avoid the downtime associated with major facelift surgery, as well as patients who have had a previous facelift and are experiencing a recurrent level of sagginess as the years go by.
Dr. Leong says Ultherapy® can lift and firm the skin of the face, neck, and brow with results that are often immediately visible. By harnessing the power of ultrasonic energy, Ultherapy® is designed to stimulate the production of collagen in soft tissues of the face, gradually providing a tightening and lifting effect. The procedure does not involve incisions or sutures; in fact, the ultrasound waves are delivered via an applicator placed against the skin in the areas targeted for treatment. Dr. Leong notes that the procedure itself does not typically involve significant levels of pain, and most individuals leave the office feeling quite comfortable.
In addition, Dr. Leong reveals that Ultherapy® is considered a "lunchtime" procedure because of its rapid treatment time -- a full facial treatment typically takes about one hour and a partial facial treatment is often just 30 minutes. He says that most patients are able to return to work or other daily activities immediately.
While Ultherapy® is not a "replacement" for traditional facelift surgery, Dr. Leong says it can serve as an effective alternative for patients who are experiencing sagging of facial, neck, and brow skin that is not too severe. He notes that results are often immediately noticeable, followed by continued improvement over the next several months. Dr. Leong says, depending on the patient's genetic makeup and lifestyle habits, the effects typically last between 12 and 18 months.
Ultimately, Dr. Leong says that Ultherapy® has proven to be one of the more reliable technologies designed to lift and tighten facial soft tissues without surgery available today. He notes that women and men who are considering Ultherapy® or other types of facial rejuvenation procedures should be sure to consult with a board-certified facial plastic surgeon or plastic surgeon who can help them determine the best option for their unique needs and goals.
About Paul L. Leong, MD
Dr. Paul Leong is the founder of Sistine Plastic Surgery, a practice offering a range of surgical and non-surgical facial rejuvenation and enhancement procedures, including facelift, rhinoplasty, eyelid surgery, laser skin resurfacing, cosmetic injectables, and many other treatments. Dr. Leong is certified by the American Board of Facial Plastic and Reconstructive Surgery and is a member of the American Academy of Facial Plastic and Reconstructive Surgery. After earning his medical degree from the Yale University School of Medicine, he completed an internship in General Surgery and a residency in Otolaryngology (head and neck surgery) at the University of Pittsburgh Medical Center. Dr. Leong has also completed a Fellowship in Facial Plastic and Reconstructive Surgery at Oregon Health Sciences University, as well as a Fellowship in Advanced Head and Neck Surgical Oncology at the University of Pittsburgh Medical Center. Dr. Leong is available for interview upon request.
For more information about Dr. Leong, Sistine Plastic Surgery, and available treatments, please visit sistineplasticsurgery.com and facebook.com/sistineplasticsurgery.
To view the original source of this press release, click here: